Phase 3 Primary Biliary Cholangitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part voluntarily and are able to understand and sign a consent form
- You are aged 18 or older but under 75 years old
- You have been diagnosed with primary biliary cholangitis (PBC) based on recognised medical guidelines, confirmed by at least two of these three things: certain positive blood markers (AMA, gp210, or sp100), an elevated liver enzyme called ALP, or specific findings on a liver tissue sample (confirm with trial site)
- You have not taken UDCA or fenofibrate (specific liver/cholesterol medicines) in the 6 months before joining, and your ALP blood level is above the normal range
Who may not be able to join:
- You have another liver condition at the same time, such as viral hepatitis, alcoholic liver disease, fatty liver disease, drug-related liver damage, autoimmune hepatitis, or primary sclerosing cholangitis
- You are pregnant, breastfeeding, or planning to become pregnant during the study
- You have a known allergy to fenofibrate or ursodeoxycholic acid (UDCA)
- You have ever had, or currently have, serious liver complications such as bleeding from swollen veins, confusion caused by liver failure, fluid build-up in the abdomen, liver cancer, or liver-kidney syndrome
- You have a history of serious problems with your heart, brain, kidneys, or lungs, or have a significant mental health condition (including those linked to alcohol or drug use)
- Your liver enzyme or bilirubin (a measure of liver function) levels are significantly above the normal range (confirm with trial site)
- Your kidney function blood test results are above or below certain thresholds (confirm with trial site)
- You have taken certain other specific liver or cholesterol medications (such as obeticholic acid or other fibrate-type drugs) within the past 6 weeks
- You have taken certain other medicines including colchicine, methotrexate, or azathioprine, or have had steroid treatment, for more than 2 weeks in the past 2 months
- You are currently taking immune-suppressing medications such as cyclosporine or tacrolimus
- You are planning to have, or have already had, an organ transplant
- You have HIV or tested positive for HIV during screening
- You have been diagnosed with or treated for cancer in the past 2 years
- The trial team considers there to be another reason you would not be suitable to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants with Normal ALP level
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.